Navela (Levonorgestrel)

Levonorgestrel works by binding to progesterone receptors, which suppresses the luteinizing hormone surge and blocks ovulation. It also alters the endometrial lining, making it less suitable for implantation should fertilization have occurred.

The specific dose of Navela is determined by the prescribing healthcare professional. Typically, an emergency contraceptive regimen involves a single oral dose taken as soon as possible after the event, but the exact amount should follow the prescriber’s instructions.

Navela is intended for use before pregnancy is established and is not a treatment for an existing pregnancy. Limited data are available for use during breastfeeding; however, occasional exposure is not expected to pose significant risk. Women should consult their healthcare provider for personalized advice.

To order Navela, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Navela contains levonorgestrel, the same active ingredient found in many other emergency contraceptive tablets. Compared with copper‑IUD insertion, it is less invasive but may have a slightly shorter window of effectiveness. Relative to newer hormonal options, levonorgestrel remains widely available, OTC in many regions, and has a well‑characterized safety profile.

Navela tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or direct sunlight.

Navela is taken orally as a tablet. The tablet should be swallowed whole with water, preferably as soon as possible after unprotected intercourse. No special preparation is required, but it is recommended to follow any additional instructions provided by the prescribing clinician.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, chest pain, and significant abdominal pain. If any of these symptoms occur, medical attention should be sought immediately. Persistent vomiting or signs of bleeding also warrant prompt evaluation.

Navela should not be used by individuals with a known hypersensitivity to levonorgestrel or any tablet excipients. Women with active liver disease, hormone‑sensitive cancers, or those who are already pregnant should avoid using it unless directed by a healthcare professional.